Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

XGN March 10, 2026

Exagen Incorporated Q4 2025 Earnings Call - Volume Momentum Hits Records, ASP Reset Delays Break-even

Exagen closed 2025 with clear commercial momentum and a tidy narrative: record revenue and accelerating test volume, but pricing pressures and new product costs have pushed the firm’s profitability in...

  • Full-year 2025 revenue was $66.6 million, up nearly 20% versus 2024.
  • Total AVISE CTD test volume for 2025 reached 137,000, driven by a second-half inflection and Q4 being the company’s highest Q4 on record.
  • Trailing 12-month ASP ended 2025 at approximately $441, up about 7% from the start of the year, but in-period ASP exited Q4 nearer to $430, reflecting a recent reset.
  • +16 more takeaways
GLRE March 10, 2026

Greenlight Capital Re, Ltd. Fourth Quarter 2025 Earnings Call - Underwriting Strength and Solasglas Gains Lifted Record 2025

Greenlight Re closed 2025 with a clean, unmistakable beat driven by underwriting and its Solasglas investment. Q4 produced a $13 million underwriting profit and a $36.2 million mark from Solasglas, co...

  • Q4 2025 underwriting profit of $13.0 million, combined ratio 92.1% (10th underwriting profit in 12 quarters).
  • Solasglas investment returned $36.2 million in Q4, a 7.9% quarterly gain, driving $44.8 million of net investment income for the quarter.
  • Net income for Q4 was $49.3 million, and full year 2025 net income was $74.8 million, lifting fully diluted book value per share to $20.43, up 13.8% year-over-year.
  • +14 more takeaways
NPWR March 10, 2026

NET Power Inc. Q4 2025 Earnings Call - Pivot to GT plus PCC with Entropy to Race for Permian FID

NET Power announced a decisive strategic pivot away from oxy-combustion toward a combined cycle gas turbine plus post-combustion capture solution, working with Entropy and OEM partners to deliver a pr...

  • NET Power formally pivoted away from oxy-combustion as its near-term commercial path, preserving the work but prioritizing a GT plus PCC route.
  • New integrated product pairs 2 Siemens SGT-A35 turbines, prepackaged by Relevant Power Solutions, with Entropy solvent-based post-combustion capture, targeting >90% CO2 capture.
  • Project Permian passed conceptual design review, and detailed design with WSP is underway, de-risking engineering and cost assumptions.
  • +12 more takeaways
NUWE March 10, 2026

Nuwellis Fourth Quarter 2025 Earnings Call - Manufacturing reset, Rendiatech buy, and $1.2M cash on hand

Nuwellis used 2025 as a reset year, shifting from broad market push to a concentrated cardiorenal strategy, moving manufacturing to KDI for reliability, and buying Rendiatech to bolster ICU diagnostic...

  • Company repositioned around the cardiorenal continuum, prioritizing heart failure and pediatrics where clinical pull and economic value align.
  • Fourth quarter 2025 revenue was $2.4 million, up 4% year-over-year and 9% sequentially, driven by increased utilization and console sales.
  • Full-year 2025 revenue was $8.3 million, a 5% decline versus 2024, reflecting lower consumable utilization and reduced international contributions.
  • +12 more takeaways
ABM March 10, 2026

ABM Industries Q1 2026 Earnings Call - Strong organic growth and cash, Technical Solutions timing weighed margins

ABM posted a solid Q1 with 5.5% organic revenue growth, $2.2 billion in revenue, and roughly $49 million in free cash flow, while management kept full year guidance intact. The quarter’s weakness was ...

  • Revenue $2.2 billion, up 6.1% year over year, driven by 5.5% organic growth.
  • Q1 net income $38.8 million, $0.64 per diluted share; adjusted net income $50.4 million, $0.83 per diluted share.
  • Free cash flow nearly $49 million in the quarter, a marked improvement driven by working capital management and ERP stabilization.
  • +13 more takeaways
KVHI March 10, 2026

KVH Industries, Inc. Q4 2025 Earnings Call - LEO Pivot Proves Out with Strong Subscriber Growth and Starlink Commitment

KVH says 2025 was the year its deliberate pivot to LEO-led maritime connectivity started to pay off. Q4 service revenue jumped to $28.3 million, service subscribers topped 9,000 vessels after adding r...

  • KVH is executing a strategic pivot from GEO to LEO-focused maritime connectivity, and management says 2025 proved the strategy is working.
  • Q4 service revenue was $28.3 million, up 27% versus Q4 2024. Full-year service revenue was $98.4 million, up 2% year over year.
  • Stripping out a $7.7 million one-time US Coast Guard contract, underlying service revenue grew about 11% in 2025, a better indicator of core momentum.
  • +11 more takeaways
INSE March 10, 2026

Inspired Entertainment Q4 2025 Earnings Call - Interactive Growth Drives Margin Turnaround Toward Mid-40s

Inspired closed 2025 with a clear inflection: digital, led by Interactive, now drives the company and pushed Q4 margin to a record 42% and full-year EBITDA to $111 million. Management is guiding 2026 ...

  • Q4 record: EBITDA margin hit 42% in the quarter, full-year 2025 EBITDA margin was 37% with EBITDA of $111 million, slightly ahead of consensus.
  • Interactive segment delivered strong Q4 growth: revenue up 53% and EBITDA up 60% year-over-year in the quarter.
  • 2026 guidance: company-wide EBITDA $112m-$118m, midpoint $115m, which represents low double-digit growth over 2025 when excluding the Holiday Parks divestiture.
  • +12 more takeaways
STGW March 10, 2026

Stagwell Inc. Q4 2025 Earnings Call - AI pivot, record cash flow, and aggressive buyback set up 2026 growth

Stagwell reported Q4 and full-year 2025 results that management says validate a strategic pivot from acquisition-led scale to product-led growth, centered on AI-enabled marketing platforms. The compan...

  • Stagwell reported 6% total revenue growth for 2025, driven by 13% growth in digital transformation and 6% growth in marketing services.
  • Management says two-year organic net revenue growth in Q4 exceeded 10%, a sequential improvement of roughly 250 basis points, signaling accelerating organic momentum into 2026.
  • 2026 guidance: total net revenue growth 8%-12%, adjusted EBITDA $475M-$525M, adjusted EPS $0.98-$1.12, and free cash flow conversion 50%-60%.
  • +12 more takeaways
LEGN March 10, 2026

Legend Biotech Q4 2025 Earnings Call - CARVYKTI Profitable; Scaling to 10,000 Annual Doses and Company Profitability in 2026

Legend closed 2025 on a fast track. CARVYKTI became profitable in 2025, delivered roughly $555 million in net trade sales in Q4, and the company reports more than 10,000 patients treated worldwide. Ma...

  • CARVYKTI became a profitable franchise in 2025, driving the company toward company-wide profitability in 2026.
  • Legend reported approximately $555 million in CARVYKTI net trade sales in Q4 2025, a 66% year-over-year increase.
  • Company revenue for Q4 was $306 million, up 64% year-over-year, with gross margin at 61% and CARVYKTI net product gross margin of 57%.
  • +12 more takeaways
ULBI March 10, 2026

Ultralife Corporation Q4 2025 Earnings Call - $110M Backlog and $12.2M Impairment Put Momentum on Notice

Ultralife closed FY2025 with tangible progress and a headline that bruises the numbers. Revenue grew to $48.5 million in Q4 and $191.2 million for the year, driven by batteries and new-product tractio...

  • Q4 revenue was $48.5 million, up 10.6% year-over-year; full year 2025 revenue was $191.2 million.
  • Management recorded a $12.2 million non-cash intangible asset impairment in Q4, driving an operating loss of $10.6 million and a GAAP net loss of $7.4 million, or $0.45 per share.
  • Backlog grew to $110.2 million exiting Q4, up $20 million (22.1%) quarter-over-quarter, and represents roughly 58% of trailing twelve months sales; management expects virtually all backlog to ship in 2026.
  • +12 more takeaways